Skip to main content
Clinical Trials/NCT07239804
NCT07239804Active, not recruitingNot Applicable

Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

Evangelical Hospital Düsseldorf5 sites in 1 country1,000 target enrollmentStarted: January 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
1,000
Locations
5
Primary Endpoint
Mortality, stroke and cardiovascular hospitalization

Study Overview

Brief Summary

The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing atrial tachycardia rhythm control

Exclusion Criteria

  • Follow-up <30 days after atrial tachycardia rhythm control

Outcomes

Primary Outcomes

Mortality, stroke and cardiovascular hospitalization

Time Frame: From AT rhythm control through study completion, an average of 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Evangelical Hospital Düsseldorf
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christian Meyer

Director of the Division of Cardiology, Electrophysiology, Angiology, Intensive Care at the EVK Düsseldorf and Principal Investigator

Evangelical Hospital Düsseldorf

Study Sites (5)

Loading locations...

Similar Trials